MK-5108

Generic Name: MK-5108

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₂H_₂₁ClFN_₃O_₃S

CAS Number: 1010085-13-8

Unique Ingredient Identifier: H8J407531S

Background: MK-5108 has been used in trials studying the treatment of Cancer, Neoplasms, Tumors.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Treatment of Participants With Advanced and/or Refractory Solid Tumors (MK-5108-001)

Phase 1

Completed

Conditions: Cancer, Neoplasms, Tumors

Interventions: Drug: MK-5108
Drug: docetaxel

First Posted Date: 2007-10-15

Last Posted Date: 2024-06-05

Lead Sponsor: Merck Sharp & Dohme LLC

Target Recruit Count: 35

Registration Number: NCT00543387

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy